The status of non-transmissible chronic disease in Mexico based on the National Health and Nutrition Survey 2006

Salud Publica de Mexico

Volumn 52, Issue SUPPL.1, 2010, Pages

  Villalpando, Salvador ^a   Rodrigo, Juan Rull ^b  

^a INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^b INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC DISEASE; CORONARY ARTERY DISEASE; EDITORIAL; HEALTH CARE POLICY; HEALTH SURVEY; HUMAN; METABOLIC SYNDROME X; MEXICO; MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITION; PUBLIC HEALTH; RISK;

CHRONIC DISEASE; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; HEALTH POLICY; HEALTH SURVEYS; HUMANS; METABOLIC SYNDROME X; MEXICO; MORBIDITY; NUTRITION SURVEYS; PUBLIC HEALTH; RISK;

EID: 78349241464     PISSN: 00363634     EISSN: 16067916     Source Type: Journal    
DOI: 10.1590/s0036-36342010000700002     Document Type: Editorial

References (16)

1. Secretaría de Salud. Subsecretaría de Prevención y Protección de la Salud. Anuarios de Morbilidad 1984-2002. México D.F. Secretaria de Salud, 2002.
2. Ford ES. Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care 2005;28:1769-1778.
3. Grundy SM, Brewer B, Cleeman JI, et al. Defnition of metabolic syndrome. Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on scientifc issues related to defnition. Circulation 2004;109:433-438.
4. Grundy SM. Metabolic Syndrome Pandemic. Arterioscler Thromb Vasc Biol 2008; 28:629-636.
5. Barquera S, Campos-Nonato I, Hernández-Barrera L, Flores M, Durazo-Arvizu R, Kanter R, Rivera JA. Obesity and central adiposity in Mexican adults: results from the Mexican National Health and Nutrition Survey 2006. Salud Pública Méx 2009; 51(sup 4):595-603.
6. Wild, S., G. Roglic, A. Green, R. Sicree, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care, 2004. 27: 1047-53.
7. World Health Organization.Diabetes(WHO). The Cost of Diabetes. WHO. Fact sheet N. 312, Nov 2008.
8. Arredondo A, Zuñiga A. Economic consequences of epidemiological changes in diabetes in middle-income countries: the Mexican case. Diabetes Care 2004;27: 104-109.
9. García-García E, Aguilar-Salinas CA, Tusié-Luna M T, Rull-Rodrigo JA. Early onset type 2 diabetes in México. Israel Med Assoc Jl 2002;4:444-448.
10. Reckless JPD. Cost-effectiveness of statin. Curr Opinion Lipidol 2000;11:351-356.
11. Córdova-Villalobos JA, Barriguete-Meléndez JA, Lara-Esqueda A, Barquera S, Rosas-Peralta M, Hernández-Avila M, León-May ME, Admon L, Aguilar-Salinas CA. Chronic non-communicable diseases in Mexico: epidemiologic synopsis and integral prevention. Salud Publica Mex. 2008; 50:419-427.
12. Sepulveda-Amor J, Lezana M, Tapia-Conyer R, Valdespino J, Madrigal H, Kumate J. Nutritional status of pre-school children and women in Mexico: results of a probabilistic national survey. Gaceta Medica de Mexico 1990;126:207-224.
13. Rivera J, Shamah T, Villalpando S, González-Cossío T, Hernández B, Sepúlveda J. Encuesta Nacional de Nutrición 1999. Cuernavaca, Morelos: INSP; 2000.
14. Secretaría de Salud, Encuesta Nacional de Enfermedades Crónicas. México, D.F.: Secretaría de Salud, 1993.
15. Olaiz G, Rojas R, Barquera S, Shamah T, Aguilar C, Cravioto P, et al. Encuesta Nacional de Salud 2000. Cuernavaca, Morelos, México: Instituto Nacional de Salud Pública; 2003.
16. Olaiz G, Rivera J, Shamah T, Rojas R, Villalpando S, Hernandez A, Sepúlveda J. Encuesta Nacional de Salud y Nutrición 2006. Cuernavaca, México: Instituto Nacional de Salud Pública; 2006.